NRX Pharmaceuticals Inc (NRXP) concluded trading on Tuesday at a closing price of $2.20, with 12.6 million shares of worth about $27.72 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.38% during that period and on December 31, 2024 the price saw a gain of about 43.79%. Currently the company’s common shares owned by public are about 11.37M shares, out of which, 9.20M shares are available for trading.
Stock saw a price change of 54.93% in past 5 days and over the past one month there was a price change of 67.94%. Year-to-date (YTD), NRXP shares are showing a performance of -52.17% which decreased to -52.17% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.10 but also hit the highest price of $7.33 during that period. The average intraday trading volume for NRX Pharmaceuticals Inc shares is 263.59K. The stock is currently trading 56.78% above its 20-day simple moving average (SMA20), while that difference is up 65.96% for SMA50 and it goes to -9.27% lower than SMA200.
NRX Pharmaceuticals Inc (NASDAQ: NRXP) currently have 11.37M outstanding shares and institutions hold larger chunk of about 5.91% of that.
The stock has a current market capitalization of $38.26M and its 3Y-monthly beta is at 1.20. It has posted earnings per share of -$2.15 in the same period. It has Quick Ratio of 0.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NRXP, volatility over the week remained 30.83% while standing at 14.77% over the month.
Stock’s fiscal year EPS is expected to rise by 53.58% while it is estimated to increase by 117.24% in next year.
